Fluoroquinolone treatment of experimental Salmonella enterica serovar Typhimurium DT104 infections in chickens selects for both gyrA mutations and changes in efflux pump gene expression
Author(s) -
Luke Randall,
Deborah J. Eaves,
S. Cooles,
Vito Ricci,
Anthony M. Buckley,
Martin J. Woodward,
Laura J. V. Piddock
Publication year - 2005
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dki189
Subject(s) - enrofloxacin , salmonella enterica , microbiology and biotechnology , nalidixic acid , biology , salmonella , strain (injury) , efflux , antibiotics , campylobacter , tetracycline , bacteria , ciprofloxacin , genetics , anatomy
To determine the efficacy of enrofloxacin (Baytril) in chickens in eradicating three different resistance phenotypes of Salmonella enterica and to examine the resistance mechanisms of resulting mutants.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom